Due: May 20, 2026 CPE CBRND is conducting essential market research for a new initiative dedicated to identifying and advancing mature, portable, and integrated mNGS systems for clinical diagnostics. The program is focused on overcoming Read More
Due: May 20, 2026 CPE CBRND is conducting essential market research for the Advanced Differential Diagnostics (ADD) program, an existing Program of Record that is developing new diagnostic capabilities in a phased approach. This program Read More
Due: May 19, 2026 Chevron wants a bold approach to radically alter how we break rocks. Unconventional thinking can deliver new and innovative solutions allowing them to extract resources more efficiently. The Chevron Rapid Engagement Read More
Due: May 5, 2026 Responding to this opportunity requires membership in the Naval Surface Technology and Innovation Consortium (NSTIC). This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end up Read More
Due: April 30, 2026 Through the Rapid Antibody Production for Immunoassay Diagnostics (RAPID) RPP, BARDA seeks to support advanced research and development of rapid antibody and other protein-based molecular recognition reagent generation platforms to enable Read More
Due: May 11, 2026 The objective of this RFI is to assess the current landscape of human-relevant neuromuscular junction (NMJ) micro-physiological systems (MPS) and their potential application for botulinum neurotoxin (BoNT) detection, potency measurement, and Read More
Due: April 15, 2026 The objective of this SSN / RFI is to better refine the requirements for host directed therapeutics for the prevention of progression to acute respiratory distress syndrome (ARDS) in support of Read More
Due: April 17, 2026 CPE CBRND is conducting essential market research for the Host-Directed Therapeutics (HD TX) program, a new initiative expected to launch in Fiscal Year 2027. This program is dedicated to identifying and Read More
Due: April 24, 2026 JPM CBRN Integrated Early Warning is developing AI/ML models to monitor physiological status, predict CBRN-related effects, and support Warfighter tactical decision making, readiness, and recovery. JPM CBRN Integrated Early Warning also Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2026 - All rights reserved.